Marshall Wace »

Enliven Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 138k 25.54
2024-06-30 $4.5M 192k 23.37

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Microsoft Corp Common Stock (MSFT)
Amazon.com Equity Option Put Option (AMZN)
Apple Common Stock (AAPL)
Meta Platforms-a Common Stock (META)
Nvidia Corp Common Stock (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Tesla Common Stock (TSLA)
Flutter Enter-di Common Stock (FLUT)
Johnson&johnson Common Stock (JNJ)
Eli Lilly & Co Common Stock (LLY)
Boston Scientifc Common Stock (BSX)
Broadcom Common Stock (AVGO)
Spdr Gold Trust Equity Option Call Option (GLD)

View all positions for Marshall Wace

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics